Lalit Bajaj
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis | 8 | 2022 | 85 | 3.580 |
Why?
| | Emergency Service, Hospital | 59 | 2025 | 2172 | 3.300 |
Why?
| | Sepsis | 11 | 2025 | 616 | 2.230 |
Why?
| | Lactic Acid | 3 | 2017 | 303 | 1.360 |
Why?
| | Bacterial Infections | 2 | 2022 | 245 | 1.240 |
Why?
| | Appendicitis | 11 | 2022 | 139 | 1.200 |
Why?
| | Hospitals, Pediatric | 13 | 2025 | 531 | 1.170 |
Why?
| | Oxygen Inhalation Therapy | 4 | 2022 | 183 | 1.130 |
Why?
| | Child | 77 | 2025 | 22308 | 1.130 |
Why?
| | Analgesics, Opioid | 6 | 2022 | 1116 | 1.090 |
Why?
| | Epilepsy | 2 | 2020 | 349 | 0.930 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2022 | 238 | 0.880 |
Why?
| | Fractures, Bone | 5 | 2021 | 404 | 0.870 |
Why?
| | Endocrine System Diseases | 3 | 2015 | 35 | 0.830 |
Why?
| | Emergencies | 4 | 2015 | 179 | 0.830 |
Why?
| | Pediatric Emergency Medicine | 2 | 2024 | 24 | 0.800 |
Why?
| | Infant | 33 | 2025 | 9818 | 0.780 |
Why?
| | Emergency Medical Services | 6 | 2019 | 647 | 0.740 |
Why?
| | Chorioamnionitis | 1 | 2022 | 43 | 0.720 |
Why?
| | Medical Overuse | 3 | 2024 | 33 | 0.720 |
Why?
| | Soft Tissue Infections | 1 | 2022 | 40 | 0.720 |
Why?
| | Craniocerebral Trauma | 3 | 2019 | 170 | 0.720 |
Why?
| | Mastitis | 1 | 2021 | 6 | 0.710 |
Why?
| | Acute Pain | 2 | 2021 | 55 | 0.710 |
Why?
| | Ketamine | 5 | 2017 | 111 | 0.710 |
Why?
| | Gastroenteritis | 1 | 2022 | 68 | 0.700 |
Why?
| | Decision Support Systems, Clinical | 6 | 2025 | 258 | 0.700 |
Why?
| | Quality Improvement | 8 | 2025 | 1244 | 0.680 |
Why?
| | Home Care Services | 2 | 2022 | 259 | 0.670 |
Why?
| | Staphylococcal Infections | 2 | 2022 | 392 | 0.670 |
Why?
| | Infant, Newborn, Diseases | 1 | 2022 | 113 | 0.660 |
Why?
| | Skin Diseases | 1 | 2022 | 147 | 0.660 |
Why?
| | Shock, Septic | 4 | 2025 | 210 | 0.630 |
Why?
| | Underage Drinking | 4 | 2021 | 23 | 0.630 |
Why?
| | Child, Preschool | 38 | 2025 | 11457 | 0.600 |
Why?
| | Humans | 94 | 2025 | 141187 | 0.600 |
Why?
| | Retrospective Studies | 30 | 2025 | 16273 | 0.590 |
Why?
| | Metabolic Diseases | 2 | 2015 | 114 | 0.590 |
Why?
| | Adolescent | 48 | 2025 | 22007 | 0.590 |
Why?
| | Plant Extracts | 1 | 2020 | 209 | 0.570 |
Why?
| | Cannabidiol | 1 | 2020 | 125 | 0.560 |
Why?
| | Anticonvulsants | 1 | 2020 | 225 | 0.560 |
Why?
| | Hospitalization | 8 | 2022 | 2255 | 0.540 |
Why?
| | Practice Patterns, Physicians' | 7 | 2022 | 1336 | 0.540 |
Why?
| | Patient Admission | 2 | 2019 | 203 | 0.520 |
Why?
| | Medical Marijuana | 1 | 2019 | 125 | 0.520 |
Why?
| | Multiple Organ Failure | 2 | 2022 | 127 | 0.500 |
Why?
| | Anti-Bacterial Agents | 6 | 2025 | 1865 | 0.500 |
Why?
| | Dronabinol | 1 | 2019 | 243 | 0.490 |
Why?
| | Hospital Mortality | 3 | 2022 | 924 | 0.490 |
Why?
| | Capnography | 1 | 2015 | 17 | 0.480 |
Why?
| | Oximetry | 1 | 2016 | 127 | 0.460 |
Why?
| | Pediatrics | 7 | 2019 | 1094 | 0.460 |
Why?
| | Infant, Newborn | 13 | 2022 | 6275 | 0.460 |
Why?
| | Health Care Costs | 1 | 2018 | 424 | 0.450 |
Why?
| | Male | 58 | 2025 | 69783 | 0.450 |
Why?
| | Airway Management | 1 | 2015 | 70 | 0.450 |
Why?
| | Fever | 2 | 2022 | 308 | 0.440 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 95 | 0.430 |
Why?
| | Patient Readmission | 3 | 2018 | 706 | 0.430 |
Why?
| | Female | 57 | 2025 | 75515 | 0.430 |
Why?
| | Clinical Laboratory Techniques | 2 | 2018 | 96 | 0.420 |
Why?
| | Electronic Health Records | 8 | 2025 | 1122 | 0.410 |
Why?
| | Asthma | 3 | 2022 | 1913 | 0.410 |
Why?
| | Anesthetics, Dissociative | 3 | 2017 | 35 | 0.410 |
Why?
| | Prospective Studies | 21 | 2025 | 7739 | 0.410 |
Why?
| | Patient Discharge | 4 | 2020 | 932 | 0.380 |
Why?
| | Patient Transfer | 1 | 2015 | 181 | 0.370 |
Why?
| | Triage | 1 | 2015 | 246 | 0.370 |
Why?
| | Intensive Care Units | 2 | 2015 | 868 | 0.370 |
Why?
| | Tertiary Healthcare | 2 | 2021 | 31 | 0.360 |
Why?
| | Emergency Treatment | 4 | 2020 | 125 | 0.350 |
Why?
| | Ambulatory Care | 3 | 2021 | 582 | 0.350 |
Why?
| | Delivery of Health Care | 1 | 2018 | 961 | 0.350 |
Why?
| | Disease Management | 1 | 2015 | 633 | 0.340 |
Why?
| | Caregivers | 3 | 2017 | 932 | 0.340 |
Why?
| | Abdominal Pain | 6 | 2016 | 145 | 0.330 |
Why?
| | Guideline Adherence | 4 | 2020 | 565 | 0.320 |
Why?
| | Sensitivity and Specificity | 9 | 2019 | 1973 | 0.320 |
Why?
| | Conscious Sedation | 4 | 2017 | 94 | 0.320 |
Why?
| | Drug Prescriptions | 3 | 2022 | 262 | 0.310 |
Why?
| | Diagnostic Errors | 3 | 2022 | 178 | 0.310 |
Why?
| | Practice Guidelines as Topic | 5 | 2018 | 1597 | 0.300 |
Why?
| | Machine Learning | 3 | 2025 | 553 | 0.300 |
Why?
| | United States | 15 | 2024 | 15220 | 0.300 |
Why?
| | Risk Assessment | 6 | 2019 | 3490 | 0.300 |
Why?
| | Vomiting | 3 | 2008 | 129 | 0.290 |
Why?
| | Cohort Studies | 10 | 2020 | 5799 | 0.290 |
Why?
| | Ondansetron | 1 | 2008 | 19 | 0.280 |
Why?
| | Cannabis | 3 | 2021 | 512 | 0.280 |
Why?
| | Quality of Health Care | 3 | 2023 | 658 | 0.270 |
Why?
| | Head Injuries, Closed | 2 | 2018 | 48 | 0.270 |
Why?
| | Antiemetics | 1 | 2008 | 48 | 0.270 |
Why?
| | Canada | 4 | 2024 | 428 | 0.260 |
Why?
| | Appendectomy | 5 | 2022 | 89 | 0.250 |
Why?
| | Pain Management | 2 | 2020 | 396 | 0.250 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2006 | 9 | 0.250 |
Why?
| | Time Factors | 11 | 2020 | 6956 | 0.240 |
Why?
| | Registries | 6 | 2025 | 2135 | 0.240 |
Why?
| | Cross-Sectional Studies | 12 | 2021 | 5636 | 0.240 |
Why?
| | Magnesium | 2 | 2020 | 157 | 0.240 |
Why?
| | Law Enforcement | 1 | 2025 | 46 | 0.230 |
Why?
| | Medical Audit | 1 | 2025 | 78 | 0.230 |
Why?
| | Police | 1 | 2025 | 45 | 0.230 |
Why?
| | Hypnotics and Sedatives | 2 | 2006 | 214 | 0.220 |
Why?
| | Length of Stay | 4 | 2025 | 1254 | 0.210 |
Why?
| | Spain | 2 | 2021 | 46 | 0.210 |
Why?
| | Intussusception | 1 | 2003 | 26 | 0.210 |
Why?
| | Orthopedic Procedures | 1 | 2006 | 229 | 0.210 |
Why?
| | Enema | 1 | 2003 | 47 | 0.200 |
Why?
| | Unnecessary Procedures | 1 | 2024 | 53 | 0.200 |
Why?
| | Anaphylaxis | 1 | 2005 | 107 | 0.200 |
Why?
| | Alcoholism | 2 | 2021 | 821 | 0.200 |
Why?
| | Acute Disease | 7 | 2020 | 1008 | 0.200 |
Why?
| | Intubation, Intratracheal | 2 | 2015 | 286 | 0.190 |
Why?
| | Critical Care | 2 | 2021 | 649 | 0.190 |
Why?
| | Metabolism, Inborn Errors | 1 | 2003 | 40 | 0.190 |
Why?
| | Tomography, X-Ray Computed | 6 | 2018 | 2746 | 0.190 |
Why?
| | Brain Injuries, Traumatic | 2 | 2018 | 400 | 0.190 |
Why?
| | Physical Examination | 2 | 2015 | 241 | 0.180 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2022 | 14 | 0.180 |
Why?
| | Drug Utilization | 3 | 2020 | 169 | 0.180 |
Why?
| | Communication Barriers | 2 | 2014 | 116 | 0.180 |
Why?
| | Prevalence | 2 | 2021 | 2772 | 0.180 |
Why?
| | Musculoskeletal Pain | 1 | 2021 | 39 | 0.180 |
Why?
| | Parental Consent | 1 | 2021 | 27 | 0.170 |
Why?
| | Substance-Related Disorders | 2 | 2021 | 1100 | 0.170 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5200 | 0.170 |
Why?
| | Antimicrobial Stewardship | 1 | 2023 | 119 | 0.170 |
Why?
| | Mass Screening | 2 | 2019 | 1310 | 0.170 |
Why?
| | Community-Acquired Infections | 1 | 2023 | 176 | 0.170 |
Why?
| | Organ Dysfunction Scores | 2 | 2022 | 52 | 0.160 |
Why?
| | Treatment Outcome | 8 | 2020 | 11120 | 0.160 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 326 | 0.160 |
Why?
| | Waiting Lists | 1 | 2022 | 244 | 0.160 |
Why?
| | Drug Hypersensitivity | 1 | 2021 | 95 | 0.160 |
Why?
| | Heuristics | 1 | 2019 | 12 | 0.150 |
Why?
| | Tracheostomy | 2 | 2015 | 140 | 0.150 |
Why?
| | Metabolic Clearance Rate | 1 | 2019 | 116 | 0.150 |
Why?
| | Half-Life | 1 | 2019 | 146 | 0.150 |
Why?
| | Biological Availability | 1 | 2019 | 137 | 0.150 |
Why?
| | Advisory Committees | 1 | 2020 | 220 | 0.150 |
Why?
| | Time-to-Treatment | 2 | 2025 | 217 | 0.150 |
Why?
| | First Aid | 1 | 2018 | 14 | 0.150 |
Why?
| | Tissue Distribution | 1 | 2019 | 330 | 0.140 |
Why?
| | Marijuana Abuse | 1 | 2021 | 231 | 0.140 |
Why?
| | Severity of Illness Index | 4 | 2015 | 2892 | 0.140 |
Why?
| | Hospitals | 2 | 2021 | 696 | 0.140 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2021 | 268 | 0.140 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2018 | 102 | 0.140 |
Why?
| | Global Health | 2 | 2015 | 386 | 0.140 |
Why?
| | Community Health Centers | 1 | 2018 | 63 | 0.140 |
Why?
| | Healthcare Disparities | 3 | 2020 | 666 | 0.140 |
Why?
| | Incidence | 5 | 2019 | 2794 | 0.140 |
Why?
| | Inpatients | 1 | 2022 | 507 | 0.140 |
Why?
| | Motivation | 1 | 2022 | 602 | 0.130 |
Why?
| | Staphylococcus aureus | 1 | 2021 | 437 | 0.130 |
Why?
| | Oxygen | 1 | 2022 | 993 | 0.130 |
Why?
| | Veins | 1 | 2017 | 70 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2018 | 178 | 0.130 |
Why?
| | Intestinal Perforation | 1 | 2017 | 45 | 0.130 |
Why?
| | Bronchodilator Agents | 1 | 2018 | 198 | 0.130 |
Why?
| | Inappropriate Prescribing | 1 | 2017 | 58 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 178 | 0.130 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 5929 | 0.130 |
Why?
| | Anemia, Sickle Cell | 1 | 2020 | 266 | 0.130 |
Why?
| | Administration, Oral | 1 | 2019 | 803 | 0.130 |
Why?
| | Prognosis | 4 | 2022 | 4073 | 0.130 |
Why?
| | Algorithms | 2 | 2019 | 1763 | 0.120 |
Why?
| | Propofol | 1 | 2017 | 89 | 0.120 |
Why?
| | Anesthetics, Intravenous | 2 | 2015 | 64 | 0.120 |
Why?
| | Comorbidity | 1 | 2021 | 1662 | 0.120 |
Why?
| | Ultrasonography | 2 | 2018 | 755 | 0.120 |
Why?
| | Ultrasonography, Doppler | 2 | 2014 | 122 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2019 | 295 | 0.120 |
Why?
| | Decision Support Techniques | 3 | 2017 | 431 | 0.120 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 248 | 0.120 |
Why?
| | Laryngeal Masks | 1 | 2015 | 16 | 0.120 |
Why?
| | Arteries | 1 | 2017 | 263 | 0.120 |
Why?
| | Logistic Models | 5 | 2025 | 2086 | 0.120 |
Why?
| | Colorado | 7 | 2020 | 4610 | 0.120 |
Why?
| | Informed Consent | 1 | 2017 | 189 | 0.110 |
Why?
| | Marijuana Smoking | 1 | 2019 | 263 | 0.110 |
Why?
| | Larynx | 1 | 2015 | 63 | 0.110 |
Why?
| | Data Collection | 1 | 2018 | 661 | 0.110 |
Why?
| | Virus Diseases | 1 | 2017 | 215 | 0.110 |
Why?
| | Spinal Fractures | 1 | 2015 | 74 | 0.110 |
Why?
| | Confidence Intervals | 2 | 2013 | 329 | 0.110 |
Why?
| | Hypotension | 1 | 2015 | 122 | 0.110 |
Why?
| | Morbidity | 1 | 2015 | 322 | 0.110 |
Why?
| | Body Temperature | 1 | 2015 | 224 | 0.110 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 194 | 0.110 |
Why?
| | Analgesia | 2 | 2005 | 102 | 0.110 |
Why?
| | International Classification of Diseases | 1 | 2015 | 138 | 0.100 |
Why?
| | Trachea | 1 | 2015 | 255 | 0.100 |
Why?
| | Burns | 1 | 2018 | 349 | 0.100 |
Why?
| | Blood Cell Count | 2 | 2013 | 54 | 0.100 |
Why?
| | Etomidate | 1 | 2012 | 8 | 0.100 |
Why?
| | Patient Selection | 1 | 2017 | 688 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 50 | 0.100 |
Why?
| | Patient Care Team | 1 | 2018 | 664 | 0.100 |
Why?
| | Telephone | 2 | 2012 | 182 | 0.100 |
Why?
| | Asymptomatic Diseases | 1 | 2013 | 92 | 0.100 |
Why?
| | Patient Compliance | 1 | 2017 | 610 | 0.090 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 93 | 0.090 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 307 | 0.090 |
Why?
| | Translating | 1 | 2012 | 47 | 0.090 |
Why?
| | Age Factors | 2 | 2016 | 3292 | 0.090 |
Why?
| | Poisoning | 1 | 2013 | 120 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2019 | 834 | 0.090 |
Why?
| | Cost Savings | 1 | 2012 | 86 | 0.090 |
Why?
| | ROC Curve | 3 | 2022 | 586 | 0.090 |
Why?
| | Emergency Medicine | 2 | 2024 | 244 | 0.090 |
Why?
| | Brain Concussion | 2 | 2016 | 580 | 0.090 |
Why?
| | Predictive Value of Tests | 3 | 2025 | 2070 | 0.090 |
Why?
| | Post-Concussion Syndrome | 1 | 2014 | 180 | 0.090 |
Why?
| | Heart Rate | 1 | 2015 | 821 | 0.090 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 434 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 186 | 0.080 |
Why?
| | Language | 2 | 2012 | 308 | 0.080 |
Why?
| | Risk | 2 | 2012 | 904 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1396 | 0.080 |
Why?
| | Intraocular Pressure | 1 | 2012 | 315 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 283 | 0.080 |
Why?
| | Electrocardiography | 1 | 2013 | 618 | 0.080 |
Why?
| | Reproducibility of Results | 5 | 2019 | 3348 | 0.080 |
Why?
| | Infusions, Intravenous | 2 | 2010 | 417 | 0.080 |
Why?
| | Spinal Puncture | 1 | 2009 | 20 | 0.080 |
Why?
| | Continuity of Patient Care | 1 | 2012 | 287 | 0.080 |
Why?
| | Communication | 2 | 2019 | 945 | 0.080 |
Why?
| | Diagnosis, Differential | 3 | 2012 | 1498 | 0.080 |
Why?
| | Bacteriological Techniques | 1 | 2009 | 67 | 0.070 |
Why?
| | Pregnancy | 1 | 2022 | 7070 | 0.070 |
Why?
| | Academic Medical Centers | 1 | 2012 | 528 | 0.070 |
Why?
| | Glasgow Coma Scale | 2 | 2017 | 203 | 0.070 |
Why?
| | Critical Illness | 1 | 2015 | 837 | 0.070 |
Why?
| | Drug Overdose | 1 | 2013 | 353 | 0.070 |
Why?
| | Age Distribution | 1 | 2009 | 395 | 0.070 |
Why?
| | Adult | 8 | 2022 | 39177 | 0.070 |
Why?
| | Urinalysis | 2 | 2013 | 77 | 0.070 |
Why?
| | Biomarkers | 2 | 2016 | 4174 | 0.070 |
Why?
| | Anti-Asthmatic Agents | 1 | 2010 | 273 | 0.070 |
Why?
| | Mental Disorders | 1 | 2016 | 1120 | 0.070 |
Why?
| | United Kingdom | 2 | 2018 | 322 | 0.070 |
Why?
| | Venous Thromboembolism | 1 | 2011 | 337 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 521 | 0.060 |
Why?
| | Anesthesia Recovery Period | 1 | 2006 | 24 | 0.060 |
Why?
| | Community Medicine | 1 | 2006 | 6 | 0.060 |
Why?
| | Fentanyl | 3 | 2015 | 120 | 0.060 |
Why?
| | Injections, Intramuscular | 1 | 2006 | 131 | 0.060 |
Why?
| | Recurrence | 2 | 2012 | 1110 | 0.060 |
Why?
| | Adrenergic Agonists | 1 | 2005 | 5 | 0.060 |
Why?
| | Potassium | 1 | 2005 | 148 | 0.060 |
Why?
| | Histamine H1 Antagonists | 1 | 2005 | 28 | 0.060 |
Why?
| | Feedback | 1 | 2025 | 179 | 0.060 |
Why?
| | Early Diagnosis | 1 | 2025 | 244 | 0.050 |
Why?
| | Hemolysis | 1 | 2005 | 201 | 0.050 |
Why?
| | Stroke | 1 | 2012 | 1154 | 0.050 |
Why?
| | Attitude | 1 | 2006 | 261 | 0.050 |
Why?
| | Fluid Therapy | 1 | 2005 | 138 | 0.050 |
Why?
| | Documentation | 1 | 2025 | 199 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 361 | 0.050 |
Why?
| | Double-Blind Method | 1 | 2008 | 1983 | 0.050 |
Why?
| | Radiography | 2 | 2015 | 844 | 0.050 |
Why?
| | Fasting | 1 | 2004 | 284 | 0.050 |
Why?
| | Blood Specimen Collection | 1 | 2002 | 37 | 0.050 |
Why?
| | Feasibility Studies | 1 | 2025 | 1018 | 0.040 |
Why?
| | Midazolam | 2 | 2015 | 72 | 0.040 |
Why?
| | Penicillins | 1 | 2021 | 59 | 0.040 |
Why?
| | Neutrophils | 2 | 2016 | 1282 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2005 | 533 | 0.040 |
Why?
| | Prescriptions | 1 | 2020 | 73 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2020 | 93 | 0.040 |
Why?
| | National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2019 | 1 | 0.040 |
Why?
| | Survival Rate | 1 | 2005 | 1970 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2022 | 3588 | 0.040 |
Why?
| | Drug Therapy, Combination | 2 | 2017 | 1040 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2020 | 161 | 0.040 |
Why?
| | Critical Pathways | 1 | 2020 | 106 | 0.040 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2018 | 20 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 704 | 0.040 |
Why?
| | Wales | 1 | 2018 | 25 | 0.040 |
Why?
| | Reference Values | 2 | 2014 | 805 | 0.040 |
Why?
| | Information Dissemination | 1 | 2020 | 224 | 0.040 |
Why?
| | Abdomen, Acute | 1 | 2018 | 22 | 0.040 |
Why?
| | Portugal | 1 | 2017 | 10 | 0.030 |
Why?
| | Ireland | 1 | 2017 | 30 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 382 | 0.030 |
Why?
| | Outpatients | 1 | 2021 | 420 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 2020 | 292 | 0.030 |
Why?
| | Quality Control | 1 | 2018 | 171 | 0.030 |
Why?
| | New Zealand | 1 | 2017 | 55 | 0.030 |
Why?
| | Research | 1 | 2021 | 455 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 222 | 0.030 |
Why?
| | Australia | 1 | 2017 | 310 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2016 | 167 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 18 | 0.030 |
Why?
| | Risk Factors | 3 | 2019 | 10438 | 0.030 |
Why?
| | Program Evaluation | 1 | 2020 | 928 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2016 | 328 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 324 | 0.030 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2015 | 19 | 0.030 |
Why?
| | Androstanols | 1 | 2015 | 20 | 0.030 |
Why?
| | Medical Order Entry Systems | 1 | 2015 | 44 | 0.030 |
Why?
| | Laryngoscopy | 1 | 2015 | 115 | 0.030 |
Why?
| | Pilot Projects | 1 | 2019 | 1820 | 0.030 |
Why?
| | Clinical Enzyme Tests | 1 | 2013 | 10 | 0.030 |
Why?
| | Students | 1 | 2019 | 645 | 0.020 |
Why?
| | Salicylates | 1 | 2013 | 29 | 0.020 |
Why?
| | Respiratory Tract Infections | 1 | 2017 | 385 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1490 | 0.020 |
Why?
| | Time Management | 1 | 2012 | 21 | 0.020 |
Why?
| | Blood Chemical Analysis | 1 | 2013 | 110 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2014 | 559 | 0.020 |
Why?
| | Recovery of Function | 1 | 2016 | 678 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1653 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2013 | 521 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1085 | 0.020 |
Why?
| | Acetaminophen | 1 | 2013 | 262 | 0.020 |
Why?
| | North America | 1 | 2010 | 306 | 0.020 |
Why?
| | Parents | 1 | 2018 | 1434 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2010 | 565 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2016 | 2902 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2012 | 695 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 13673 | 0.020 |
Why?
| | Seizures, Febrile | 1 | 2006 | 22 | 0.020 |
Why?
| | Potassium Acetate | 1 | 2005 | 2 | 0.020 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 43 | 0.010 |
Why?
| | Respiration Disorders | 1 | 2004 | 79 | 0.010 |
Why?
| | Middle Aged | 2 | 2019 | 34434 | 0.010 |
Why?
| | Respiratory Tract Diseases | 1 | 2005 | 181 | 0.010 |
Why?
| | Linear Models | 1 | 2005 | 857 | 0.010 |
Why?
| | Analgesics | 1 | 2005 | 226 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2005 | 2087 | 0.010 |
Why?
|
|
Bajaj's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|